These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24402707)

  • 21. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma.
    Yue D; Fan Q; Chen X; Li F; Wang L; Huang L; Dong W; Chen X; Zhang Z; Liu J; Wang F; Wang M; Zhang B; Zhang Y
    Exp Cell Res; 2014 Mar; 322(1):149-58. PubMed ID: 24269829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRSS8 methylation and its significance in esophageal squamous cell carcinoma.
    Bao Y; Wang Q; Guo Y; Chen Z; Li K; Yang Y; Zhang H; Dong H; Shen K; Yang W
    Oncotarget; 2016 May; 7(19):28540-55. PubMed ID: 27081034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant promoter methylation of the TPEF gene in esophageal squamous cell carcinoma.
    Zhao BJ; Tan SN; Cui Y; Sun DG; Ma X
    Dis Esophagus; 2008; 21(7):582-8. PubMed ID: 19040536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
    Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
    Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
    Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L
    Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal evolution in caveolin 1 methylation levels during human esophageal carcinogenesis.
    Jin Z; Wang L; Cao Z; Cheng Y; Gao Y; Feng X; Chen S; Yu H; Wu W; Zhao Z; Dong M; Zhang X; Liu J; Fan X; Mori Y; Meltzer SJ
    BMC Cancer; 2014 May; 14():345. PubMed ID: 24885118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells.
    Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y
    Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo W; Zhu T; Dong Z; Cui L; Zhang M; Kuang G
    Clin Exp Metastasis; 2013 Dec; 30(8):977-92. PubMed ID: 23793925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
    Yang SH; Li SL; Dong ZM; Kan QC
    Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
    Sonoda I; Imoto I; Inoue J; Shibata T; Shimada Y; Chin K; Imamura M; Amagasa T; Gray JW; Hirohashi S; Inazawa J
    Cancer Res; 2004 Jun; 64(11):3741-7. PubMed ID: 15172977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
    Chen C; Ma Z; Zhang H; Liu X; Yu Z
    Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repression of DOK7 mediated by DNMT3A promotes the proliferation and invasion of KYSE410 and TE-12 ESCC cells.
    Yang SM; Li SY; Yu HB; Li JR; Sun LL
    Biomed Pharmacother; 2017 Jun; 90():93-99. PubMed ID: 28343076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
    Guo W; Wang C; Guo Y; Shen S; Guo X; Kuang G; Dong Z
    Clin Exp Metastasis; 2015 Jan; 32(1):83-98. PubMed ID: 25579665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
    Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
    Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.